Published in Biochem Biophys Res Commun on July 16, 2004
TGF-β and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci (2012) 3.49
Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-beta. J Clin Invest (2006) 1.76
Molecular genetic studies of gene identification for osteoporosis: a 2004 update. J Bone Miner Res (2006) 1.52
BMP9 signaling in stem cell differentiation and osteogenesis. Am J Stem Cells (2013) 1.17
Specific expression of BMP2/4 ortholog in biomineralizing tissues of corals and action on mouse BMP receptor. Mar Biotechnol (NY) (2008) 1.11
Graft healing in anterior cruciate ligament reconstruction. Sports Med Arthrosc Rehabil Ther Technol (2009) 0.91
Acetylcholine induces mesenchymal stem cell migration via Ca2+ /PKC/ERK1/2 signal pathway. J Cell Biochem (2012) 0.89
TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res (2016) 0.88
Analysis of BMP4 and BMP7 signaling in breast cancer cells unveils time-dependent transcription patterns and highlights a common synexpression group of genes. BMC Med Genomics (2011) 0.84
Targeting BMP signalling in cardiovascular disease and anaemia. Nat Rev Cardiol (2015) 0.82
Time series gene expression profiling and temporal regulatory pathway analysis of BMP6 induced osteoblast differentiation and mineralization. BMC Syst Biol (2011) 0.81
Bone morphogenetic protein 2 promotes primordial follicle formation in the ovary. Sci Rep (2015) 0.78
Hairy/enhancer-of-split related with YRPW motif protein 1 promotes osteosarcoma metastasis via matrix metallopeptidase 9 expression. Br J Cancer (2015) 0.76
Evaluating Osteogenic Potential of Ligamentum Flavum Cells Cultivated in Photoresponsive Hydrogel that Incorporates Bone Morphogenetic Protein-2 for Spinal Fusion. Int J Mol Sci (2015) 0.75
Notch signaling pathway promotes osteogenic differentiation of mesenchymal stem cells by enhancing BMP9/Smad signaling. Int J Mol Med (2017) 0.75
MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J (1996) 4.13
Least absolute regression network analysis of the murine osteoblast differentiation network. Bioinformatics (2005) 1.50
Isolation and identification of the human homolog of a new p53-binding protein, Mdmx. Genomics (1997) 1.37
Lysines 72, 80 and 213 and aspartic acid 210 of the Lactococcus lactis LacR repressor are involved in the response to the inducer tagatose-6-phosphate leading to induction of lac operon expression. Protein Eng (1993) 0.97
Human progesterone receptor A and B isoforms in CHO cells. I. Stable transfection of receptor and receptor-responsive reporter genes: transcription modulation by (anti)progestagens. J Steroid Biochem Mol Biol (1998) 0.87
Human serotonin 5-HT7 receptor: cloning and pharmacological characterisation of two receptor variants. FEBS Lett (1997) 0.86
Genomic organization of the human bone morphogenetic protein-4 gene: molecular basis for multiple transcripts. Biochem Biophys Res Commun (1996) 0.84
Role of Trpc channels, Stim1 and Orai1 in PGF(2α)-induced calcium signaling in NRK fibroblasts. Cell Calcium (2011) 0.83
Functional characterization of two promoters in the human bone morphogenetic protein-4 gene. J Bone Miner Res (1999) 0.83
Genomic organisation and functional expression of the gene encoding the human serotonin 5-HT2C receptor. Eur J Pharmacol (1994) 0.82
Repression of the minimal HLA-B promoter by c-myc and p53 occurs through independent mechanisms. Mol Immunol (1998) 0.82
GM1492 human diploid skin fibroblasts lack the p53-dependent G1 cell-cycle checkpoint. Biochem Biophys Res Commun (1995) 0.81
Cell-type-specific modulation of Hox gene expression by members of the TGF-beta superfamily: a comparison between human osteosarcoma and neuroblastoma cell lines. Biochem Biophys Res Commun (1997) 0.81
Fine mapping of the human bone morphogenetic protein-4 gene (BMP4) to chromosome 14q22-q23 by in situ hybridization. Genomics (1995) 0.80
Homeobox proteins as signal transduction intermediates in regulation of NCAM expression by recombinant human bone morphogenetic protein-2 in osteoblast-like cells. Mol Cell Biol Res Commun (1999) 0.79
Autocrine production of prostaglandin F2alpha enhances phenotypic transformation of normal rat kidney fibroblasts. Am J Physiol Cell Physiol (2005) 0.79
Genomic organization, coding sequence and functional expression of human 5-HT2 and 5-HT1A receptor genes. Eur J Pharmacol (1992) 0.79
Antiestrogens specifically up-regulate bone morphogenetic protein-4 promoter activity in human osteoblastic cells. Mol Endocrinol (2000) 0.79
Immortalization of antigen selected B cells. J Immunol Methods (1993) 0.79
Role of the prostanoid FP receptor in action potential generation and phenotypic transformation of NRK fibroblasts. Cell Signal (2008) 0.78
Growth-dependent modulation of capacitative calcium entry in normal rat kidney fibroblasts. Cell Signal (2010) 0.77
Cloning and characterization of the human sperm receptor ligand ZP3: evidence for a second polymorphic allele with a different frequency in the Caucasian and Japanese populations. Genomics (1992) 0.76
c-myc-induced natural killer cell sensitivity of human melanoma cells is reversed by HLA-B27 transfection. Eur J Immunol (1992) 0.76
Molecular cloning and characterization of a novel orphan receptor (P2P) expressed in human pancreas that shows high structural homology to the P2U purinoceptor. FEBS Lett (1996) 0.76
Different roles of inositol 1,4,5-trisphosphate receptor subtypes in prostaglandin F(2alpha)-induced calcium oscillations and pacemaking activity of NRK fibroblasts. Cell Calcium (2010) 0.76
Local induction of pacemaking activity in a monolayer of electrically coupled quiescent NRK fibroblasts. Cell Calcium (2008) 0.76
"The coming of wonders". Fertil Steril (1997) 0.75
The human gene for the zona pellucida glycoprotein ZP3 and a second polymorphic locus are located on chromosome 7. Cytogenet Cell Genet (1993) 0.75
Bloom's syndrome cells GM1492 lack detectable p53 protein but exhibit normal G1 cell-cycle arrest after UV irradiation. Oncogene (1994) 0.75
A new approach to the generation of human or murine antibody producing hybridomas. J Immunol Methods (1992) 0.75